BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16638818)

  • 21. Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.
    Dennison JB; Jones DR; Renbarger JL; Hall SD
    J Pharmacol Exp Ther; 2007 May; 321(2):553-63. PubMed ID: 17272675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs.
    Walsky RL; Obach RS; Hyland R; Kang P; Zhou S; West M; Geoghegan KF; Helal CJ; Walker GS; Goosen TC; Zientek MA
    Drug Metab Dispos; 2012 Sep; 40(9):1686-97. PubMed ID: 22645092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide).
    Tseng E; Walsky RL; Luzietti RA; Harris JJ; Kosa RE; Goosen TC; Zientek MA; Obach RS
    Drug Metab Dispos; 2014 Jul; 42(7):1163-73. PubMed ID: 24737844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP3A4/5 Activity Probed with Testosterone and Midazolam: Correlation between Two Substrates at the Microsomal and Enzyme Levels.
    Xiao K; Gao J; Weng SJ; Fang Y; Gao N; Wen Q; Jin H; Qiao HL
    Mol Pharm; 2019 Jan; 16(1):382-392. PubMed ID: 30517006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone.
    Kamdem LK; Meineke I; Koch I; Zanger UM; Brockmöller J; Wojnowski L
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):71-7. PubMed ID: 15232676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of the minor cytochrome P450 3A isoforms.
    Daly AK
    Clin Pharmacokinet; 2006; 45(1):13-31. PubMed ID: 16430309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5.
    Klees TM; Sheffels P; Thummel KE; Kharasch ED
    Anesthesiology; 2005 Mar; 102(3):550-6. PubMed ID: 15731592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests.
    Lee SJ; Goldstein JA
    Pharmacogenomics; 2005 Jun; 6(4):357-71. PubMed ID: 16004554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of Action of Panaxytriol on Midazolam 1'-Hydroxylation and 4-Hydroxylation Mediated by CYP3A in Liver Microsomes and Rat Primary Hepatocytes.
    He F; Zhang W; Zeng C; Xia C; Xiong Y; Zhang H; Huang S; Liu M
    Biol Pharm Bull; 2015; 38(10):1470-7. PubMed ID: 26424012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.
    Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD
    Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a highly selective CYP3A4 inhibitor suitable for reaction phenotyping studies and differentiation of CYP3A4 and CYP3A5.
    Li X; Song X; Kamenecka TM; Cameron MD
    Drug Metab Dispos; 2012 Sep; 40(9):1803-9. PubMed ID: 22696420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
    Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
    Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
    Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
    Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
    Thummel KE; Shen DD; Podoll TD; Kunze KL; Trager WF; Hartwell PS; Raisys VA; Marsh CL; McVicar JP; Barr DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):549-56. PubMed ID: 7965755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.
    Hesse LM; He P; Krishnaswamy S; Hao Q; Hogan K; von Moltke LL; Greenblatt DJ; Court MH
    Pharmacogenetics; 2004 Apr; 14(4):225-38. PubMed ID: 15083067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam.
    Granvil CP; Yu AM; Elizondo G; Akiyama TE; Cheung C; Feigenbaum L; Krausz KW; Gonzalez FJ
    Drug Metab Dispos; 2003 May; 31(5):548-58. PubMed ID: 12695342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of organic solvents on cytochrome P450 probe reactions: filling the gap with (S)-Warfarin and midazolam hydroxylation.
    González-Pérez V; Connolly EA; Bridges AS; Wienkers LC; Paine MF
    Drug Metab Dispos; 2012 Nov; 40(11):2136-42. PubMed ID: 22896727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 1Beta- and 5Beta-hydroxylation of Deoxycholate and Glycodeoxycholate as In Vitro Index Reactions for Cytochrome P450 3A Activities.
    Wang C; Cheng B; Wei W; Gui L; Zeng W; Wang Y; Wang Y; Chen Q; Xu L; Miao J; Lan K
    Drug Metab Dispos; 2024 Jan; 52(2):126-134. PubMed ID: 38050044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.